Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kensuke Takagi

Showing results (241-250 of 253) with videos related to

Pageof 26
Sort By:
International Journal of Cardiology. Heart & Vasculature|May 1, 2026
Peak aortic jet velocity as a predictor of short- and long-term outcomes following percutaneous coronary interventionTakamasa Iwai, Kensuke Takagi, Takeshi Kitai, et al.
Circulation. Cardiovascular Interventions|May 18, 2021
Very Short Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation in Patients Who Underwent Complex Percutaneous Coronary Intervention: Insight From the STOPDAPT-2 TrialKo Yamamoto, Hirotoshi Watanabe, Takeshi Morimoto, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|July 8, 2025
Intra- versus supra-annular self-expanding transcatheter heart valves in small aortic annuliMasanori Yamamoto, Toshinobu Ryuzaki, Hirofumi Hioki, et al.
Journal of Clinical Lipidology|June 24, 2025
Circulating apolipoprotein B levels in statin-treated type 2 diabetic patients with coronary artery disease: Implications for coronary atheroma progression and instabilitySayaka Funabashi, Yu Kataoka, Stephen J Nicholls, et al.
Atherosclerosis Plus|April 15, 2024
Glucagon-like Peptide-1 analogues and delipidation of coronary atheroma in statin-treated type 2 diabetic patients with coronary artery disease: The prespecified sub-analysis of the OPTIMAL randomized clinical trialYu Kataoka, Satoshi Kitahara, Sayaka Funabashi, et al.
Journal of Clinical Lipidology|January 21, 2026
Different response of plaque regression following achievement of LDL-C <1.8 mmol/L in obese and non-obese patients with diabetes and coronary artery disease: OPTIMAL sub-analysisAnthony Salib, Yu Kataoka, Stephen J Nicholls, et al.
The American Journal of Cardiology|September 3, 2023
SYNTAX Score and 1-Year Outcomes in the OPTIVUS-Complex PCI Study Multivessel CohortMasaomi Gohbara, Kiyoshi Hibi, Takeshi Morimoto, et al.
Cardiovascular Intervention and Therapeutics|April 6, 2025
Complex PCI and 1-year outcomes in the OPTIVUS-complex PCI study multivessel cohortMasaomi Gohbara, Kiyoshi Hibi, Takeshi Morimoto, et al.
The American Journal of Cardiology|March 10, 2025
Hemolytic Anemia Following SAPIEN 3 Ultra RESILIA Implantation (from the OCEAN-TAVI Registry)Kenichi Ishizu, Shinichi Shirai, Masaomi Hayashi, et al.
Journal of Diabetes and Its Complications|September 23, 2023
The effect of continuous glucose monitoring-guided glycemic control on progression of coronary atherosclerosis in type 2 diabetic patients with coronary artery disease: The OPTIMAL randomized clinical trialYu Kataoka, Satoshi Kitahara, Sayaka Funabashi, et al.
Pageof 26

Showing results (241-250 of 253) with videos related to

Sort By:
Pageof 26
International Journal of Cardiology. Heart & Vasculature|May 1, 2026
Peak aortic jet velocity as a predictor of short- and long-term outcomes following percutaneous coronary interventionTakamasa Iwai, Kensuke Takagi, Takeshi Kitai, et al.
Circulation. Cardiovascular Interventions|May 18, 2021
Very Short Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation in Patients Who Underwent Complex Percutaneous Coronary Intervention: Insight From the STOPDAPT-2 TrialKo Yamamoto, Hirotoshi Watanabe, Takeshi Morimoto, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|July 8, 2025
Intra- versus supra-annular self-expanding transcatheter heart valves in small aortic annuliMasanori Yamamoto, Toshinobu Ryuzaki, Hirofumi Hioki, et al.
Journal of Clinical Lipidology|June 24, 2025
Circulating apolipoprotein B levels in statin-treated type 2 diabetic patients with coronary artery disease: Implications for coronary atheroma progression and instabilitySayaka Funabashi, Yu Kataoka, Stephen J Nicholls, et al.
Atherosclerosis Plus|April 15, 2024
Glucagon-like Peptide-1 analogues and delipidation of coronary atheroma in statin-treated type 2 diabetic patients with coronary artery disease: The prespecified sub-analysis of the OPTIMAL randomized clinical trialYu Kataoka, Satoshi Kitahara, Sayaka Funabashi, et al.
Journal of Clinical Lipidology|January 21, 2026
Different response of plaque regression following achievement of LDL-C <1.8 mmol/L in obese and non-obese patients with diabetes and coronary artery disease: OPTIMAL sub-analysisAnthony Salib, Yu Kataoka, Stephen J Nicholls, et al.
The American Journal of Cardiology|September 3, 2023
SYNTAX Score and 1-Year Outcomes in the OPTIVUS-Complex PCI Study Multivessel CohortMasaomi Gohbara, Kiyoshi Hibi, Takeshi Morimoto, et al.
Cardiovascular Intervention and Therapeutics|April 6, 2025
Complex PCI and 1-year outcomes in the OPTIVUS-complex PCI study multivessel cohortMasaomi Gohbara, Kiyoshi Hibi, Takeshi Morimoto, et al.
The American Journal of Cardiology|March 10, 2025
Hemolytic Anemia Following SAPIEN 3 Ultra RESILIA Implantation (from the OCEAN-TAVI Registry)Kenichi Ishizu, Shinichi Shirai, Masaomi Hayashi, et al.
Journal of Diabetes and Its Complications|September 23, 2023
The effect of continuous glucose monitoring-guided glycemic control on progression of coronary atherosclerosis in type 2 diabetic patients with coronary artery disease: The OPTIMAL randomized clinical trialYu Kataoka, Satoshi Kitahara, Sayaka Funabashi, et al.
Pageof 26